23 Apr Sleep data startup EnsoData earns FDA clearance
EnsoData, a Madison health IT company barely two years old, has won clearance from the U.S. Food and Drug Administration to sell its sleep-analysis software.
“It’s probably the biggest milestone for our company so far,” said CEO and co-founder Chris Fernandez, 24. “We can legally sell it … all across the United States.”
EnsoData’s software, EnsoSleep, automatically scores the findings of sleep studies by recording and analyzing conditions such as sleep apnea or respiratory-related sleep problems, and stores the results in the computer cloud.
Sorry, the comment form is closed at this time.